SusanJLindemulderMD

Pediatric Hematology & Oncology • Portland, OR

Assistant Professor, Pediatrics, Oregon Health and Science University School of Medicine

Join to view full profile

Dr. Lindemulder is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Lindemulder's full profile

Already have an account?

Office
3181 Sw Sam Jackson Park Rd
Portland, OR 97239
Phone+1 503-418-5456

Fax+1 503-494-0714

Education & Training

University of ColoradoFellowship, Pediatric Hematology/Oncology, 2003 - 2008
University of ColoradoResidency, Pediatrics, 2000 - 2003
Northwestern University The Feinberg School of MedicineClass of 2000

Certifications & Licensure

OR State Medical License 2008 - 2025
AK State Medical License 2012 - 2014
CO State Medical License 2006 - 2009
American Board of Pediatrics Pediatric Hematology-Oncology

Clinical Trials

Isotretinoin With or Without Dinutuximab, Aldesleukin, and Sargramostim Following Stem Cell Transplant in Treating Patients With Neuroblastoma Start of enrollment: 2001 Oct 18
ACTIVE_NOT_RECRUITING
PHASE3
Risk-Adapted Chemotherapy in Treating Younger Patients With Newly Diagnosed Standard-Risk Acute Lymphoblastic Leukemia or Localized B-Lineage Lymphoblastic Lymphoma Start of enrollment: 2010 Aug 09
Active, not recruiting
Phase 3
Irinotecan Hydrochloride and Temozolomide With Temsirolimus or Dinutuximab in Treating Younger Patients With Refractory or Relapsed Neuroblastoma Start of enrollment: 2013 Feb 12
Completed
Phase 2
Brentuximab Vedotin and Gemcitabine Hydrochloride in Treating Younger Patients With Relapsed or Refractory Hodgkin Lymphoma Start of enrollment: 2013 Jan 31
Completed
Phase 1, Phase 2
Provider-Focused Intervention for Maximizing HPV Vaccine Uptake in Young Cancer Survivors Start of enrollment: 2021 Feb 01
ACTIVE_NOT_RECRUITING
NA
Roles: Contact
Join now to see all

Publications & Presentations

PubMed

4 citations
Family perspectives on the transition from active treatment to survivorship for children with cancer.
Kellee Parker, Vivian Christensen, Susan Lindemulder, Lai Hin Kimi Chan, Lauren Saxton
Pediatric Blood & Cancer. 2023-10-01
Hopping as an Indicator of Chemotoxicity: Gait Analysis in Patients With Leukemia and Lymphoma.
Kellee Parker, Nancy Durben, David Oleson, Yun Yu, Jeong Y Lim
Journal of Pediatric Hematology/oncology. 2023-07-01
13 citations
Sodium thiosulfate as cisplatin otoprotectant in children: The challenge of when to use it.
Penelope Brock, Annelot Meijer, Per Kogner, Marc Ansari, Michael Capra
Pediatric Blood & Cancer. 2023-05-01